Angela L Hewlett1, Jay B Varkey, Philip W Smith, Bruce S Ribner. 1. aDivision of Infectious Diseases, Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska bDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Abstract
PURPOSE OF REVIEW: This review details infection control issues encountered in the management of patients with Ebola virus disease (EVD), with emphasis on how these issues were confronted in two biocontainment patient care units in the United States. RECENT FINDINGS: There is a notable paucity of medical literature to guide infection control policies and procedures when caring for patients with EVD. Thus, the experience of the Serious Communicable Diseases Unit at Emory University Hospital and the Nebraska Biocontainment Unit at the University of Nebraska Medical Center serves as the basis for this review. Facility issues, staffing, transportation logistics, and appropriate use of personal protective equipment are detailed. Other topics addressed include the evaluation of patients under investigation and ethical issues concerning the safe utilization of advanced life support. SUMMARY: This review intends to serve as a reference for facilities that are in the process of creating protocols for managing patients with EVD. Given the lack of literature to support many of the recommendations discussed, it is important to utilize the available referenced guidelines, along with the practical experiences of biocontainment units, to optimize the care provided to patients with EVD while strictly adhering to infection control principles.
PURPOSE OF REVIEW: This review details infection control issues encountered in the management of patients with Ebola virus disease (EVD), with emphasis on how these issues were confronted in two biocontainment patient care units in the United States. RECENT FINDINGS: There is a notable paucity of medical literature to guide infection control policies and procedures when caring for patients with EVD. Thus, the experience of the Serious Communicable Diseases Unit at Emory University Hospital and the Nebraska Biocontainment Unit at the University of Nebraska Medical Center serves as the basis for this review. Facility issues, staffing, transportation logistics, and appropriate use of personal protective equipment are detailed. Other topics addressed include the evaluation of patients under investigation and ethical issues concerning the safe utilization of advanced life support. SUMMARY: This review intends to serve as a reference for facilities that are in the process of creating protocols for managing patients with EVD. Given the lack of literature to support many of the recommendations discussed, it is important to utilize the available referenced guidelines, along with the practical experiences of biocontainment units, to optimize the care provided to patients with EVD while strictly adhering to infection control principles.
Authors: John J Lowe; Shawn G Gibbs; Shelly S Schwedhelm; John Nguyen; Philip W Smith Journal: Am J Infect Control Date: 2014-11-25 Impact factor: 2.918
Authors: Peter C Iwen; Philip W Smith; Angela L Hewlett; Christopher J Kratochvil; Steven J Lisco; James N Sullivan; Shawn G Gibbs; John J Lowe; Paul D Fey; Vicki L Herrera; Anthony R Sambol; James L Wisecarver; Steven H Hinrichs Journal: Am J Clin Pathol Date: 2015-01 Impact factor: 2.493
Authors: Charles E Hill; Eileen M Burd; Colleen S Kraft; Emily L Ryan; Alexander Duncan; Anne M Winkler; John C Cardella; James C Ritchie; Tristram G Parslow Journal: Lab Med Date: 2014
Authors: Daniel W Johnson; James N Sullivan; Craig A Piquette; Angela L Hewlett; Kristina L Bailey; Philip W Smith; Andre C Kalil; Steven J Lisco Journal: Crit Care Med Date: 2015-06 Impact factor: 7.598
Authors: Courtney C Moreno; Colleen S Kraft; Sharon Vanairsdale; Prem Kandiah; Matthew A Klopman; Bruce S Ribner; Srini Tridandapani Journal: AJR Am J Roentgenol Date: 2015-03-02 Impact factor: 3.959
Authors: Philip W Smith; Arthur O Anderson; George W Christopher; Theodore J Cieslak; G J Devreede; Glen A Fosdick; Carl B Greiner; John M Hauser; Steven H Hinrichs; Kermit D Huebner; Peter C Iwen; Dawn R Jourdan; Mark G Kortepeter; V Paul Landon; Patricia A Lenaghan; Robert E Leopold; Leroy A Marklund; James W Martin; Sharon J Medcalf; Robert J Mussack; Randall H Neal; Bruce S Ribner; Jonathan Y Richmond; Chuck Rogge; Leo A Daly; Gary A Roselle; Mark E Rupp; Anthony R Sambol; Joann E Schaefer; John Sibley; Andrew J Streifel; Susanna G Von Essen; Kelly L Warfield Journal: Biosecur Bioterror Date: 2006
Authors: Alexander Isakov; Wade Miles; Shawn Gibbs; John Lowe; Aaron Jamison; Raymond Swansiger Journal: Ann Emerg Med Date: 2015-05-21 Impact factor: 5.721
Authors: Brian T Garibaldi; Mallory Reimers; Neysa Ernst; Gregory Bova; Elaine Nowakowski; James Bukowski; Brandon C Ellis; Chris Smith; Lauren Sauer; Kim Dionne; Karen C Carroll; Lisa L Maragakis; Nicole M Parrish Journal: J Clin Microbiol Date: 2016-12-07 Impact factor: 5.948
Authors: Benjamin K Kogutt; Jeanne S Sheffield; Dianne Whyne; Lisa L Maragakis; Jennifer Andonian; Jade Flinn; Chris Sulmonte; Adam Dodson; Mark Romig; Lauren Sauer; Robert Maloney; Janis Ferrell; Arthur J Vaught; W Christopher Golden; Brian T Garibaldi Journal: Health Secur Date: 2019 Jan/Feb
Authors: Mark G Kortepeter; Theodore J Cieslak; Elena H Kwon; Philip W Smith; Christopher J Kratochvil; Angela L Hewlett Journal: Biomed Res Int Date: 2017-09-20 Impact factor: 3.411
Authors: Colleen S Kraft; Aneesh K Mehta; Jay B Varkey; G Marshall Lyon; Sharon Vanairsdale; Sonia Bell; Eileen M Burd; Mary Elizabeth Sexton; Leslie Anne Cassidy; Patricia Olinger; Kalpana Rengarajan; Vanessa N Raabe; Emily Davis; Scott Henderson; Paula DesRoches; Yongxian Xu; Mark J Mulligan; Bruce S Ribner Journal: Infect Control Hosp Epidemiol Date: 2020-01-20 Impact factor: 6.520
Authors: J J Mark Haverkort; A L C Ben Minderhoud; Jelte D D Wind; Luke P H Leenen; Andy I M Hoepelman; Pauline M Ellerbroek Journal: Emerg Infect Dis Date: 2016-02 Impact factor: 6.883